An increased incidence of cardiovascular events, including myocardial infarctions were observed in patients taking PD-1/PD-L1 immune checkpoint inhibitors, which sparked interest in elucidating the pathway's involvement in acute coronary syndrome [16,17]. The gene discussed is PDCD1; the disease is myocardial infarction.